ArticleFrontiers in cell and developmental biology2021

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment.

Di Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.